Absci (ABSI) Total Liabilities (2020 - 2026)
Absci (ABSI) reported Total Liabilities of $23.6 million for Q1 2026, down 29.8% on a YoY basis from $33.7 million in Q1 2025, and down 12.02% sequentially from $26.8 million in Q4 2025.
Absci (ABSI) Total Liabilities (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Total Liabilities data on file, last reported at $23.6 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities fell 29.8% year-over-year to $23.6 million; the trailing twelve-month figure through Mar 2026 stood at $23.6 million (down 29.8% YoY), and the FY2025 full-year result was $26.8 million, down 22.12% from the prior year.
- Total Liabilities declined to $23.6 million in Q1 2026, from $26.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $55.0 million in Q1 2022 to a low of $23.6 million in Q1 2026.
- A 5-year average of $38.4 million and a median of $36.5 million in 2025 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities plunged 77.21% in 2022 and rose 7.28% in 2025, its largest moves.
- Tracing ABSI's Total Liabilities over 5 years: stood at $46.6 million in 2022, then dropped by 11.74% to $41.1 million in 2023, then retreated by 16.16% to $34.5 million in 2024, then declined by 22.12% to $26.8 million in 2025, then decreased by 12.02% to $23.6 million in 2026.
- Business Quant data shows ABSI's Total Liabilities at $23.6 million in Q1 2026, $26.8 million in Q4 2025, and $34.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | 23.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.62 Mn |
| Dec 31, 2025 | 26.85 Mn |
| Sep 30, 2025 | 34.65 Mn |
| Jun 30, 2025 | 36.52 Mn |
| Mar 31, 2025 | 33.65 Mn |
| Dec 31, 2024 | 34.48 Mn |
| Sep 30, 2024 | 33.90 Mn |
| Jun 30, 2024 | 34.04 Mn |
| Mar 31, 2024 | 34.79 Mn |
| Dec 31, 2023 | 41.12 Mn |
| Sep 30, 2023 | 39.93 Mn |
| Jun 30, 2023 | 38.75 Mn |
| Mar 31, 2023 | 41.84 Mn |
| Dec 31, 2022 | 46.59 Mn |
| Sep 30, 2022 | 46.45 Mn |
| Jun 30, 2022 | 50.12 Mn |
| Mar 31, 2022 | 54.96 Mn |
| Dec 31, 2021 | 60.09 Mn |
| Sep 30, 2021 | 61.11 Mn |
| Jun 30, 2021 | 219.96 Mn |